Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Chembio Diagnostics- Inc. (CEMI)

10.15 -0.2 (-1.93%)

06-19 10:03

Open:

10.25

Pre. Close:

10.35

High:

10.25

Low:

9.95

Volume:

2,401

Market Cap:

144M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

10.36 - 10.41

10.41 - 10.453

Low:

9.881 - 9.939

9.939 - 9.988

Close:

10.262 - 10.353

10.353 - 10.431

Technical analysis  (as of: 2018-06-19 10:23:30 AM)

Overall:

      

Stoxline posted a SELL today, downgraded from higher rating. This stock seems to be ready for a new bearish move. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell now, downward move is expected.

Target:

Six months: 12.26     One year: 14.32

Support:

Support1: 9.27    Support2: 8.51

Resistance:

Resistance1: 10.50    Resistance2: 12.26

Pivot:

10.16

Moving Averages:

MA(5): 10.32     MA(20): 9.90

MA(100): 8.33     MA(250): 7.34

MACD:

MACD(12,26): 0.44     Signal(12,26,9): 0.47

%K %D:

%K(14,3): 81.78     %D(3): 88.04

RSI:

RSI(14): 65.95

52-Week:

High: 10.5  Low: 5.7  Change(%): 61.3

Average Vol(K):

3-Month: 2799  10-Days 1971

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
CEMI has closed below upper band by 49.8%. Bollinger Bands are 18.8% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

2018-05-12T07:48:02-04:00
Chembio Diagnostics' (CEMI) CEO John Sperzel on Q1 2018 Results - Earnings Call Transcript

2018-05-09T16:33:39-04:00
Chembio Diagnostics beats by $0.09, beats on revenue

2018-03-09T00:16:06-05:00
Chembio Diagnostics' (CEMI) CEO John Sperzel on Q4 2017 Results - Earnings Call Transcript

2018-03-08T16:16:06-05:00
Chembio Diagnostics misses by $0.06, beats on revenue

2018-02-10T08:00:00-05:00
Your Daily Pharma Scoop: GW Pharmaceuticals Pullback, Seattle Genetics Announces Collaboration Agreement, Catalyst Reports Data

2017-11-11T17:04:03-05:00
Chembio Diagnostics' (CEMI) CEO John Sperzel on Q3 2017 Results - Earnings Call Transcript

2017-11-08T16:49:33-05:00
Chembio Diagnostics beats by $0.06, beats on revenue

2017-08-10T23:12:39-04:00
Chembio Diagnostics, Inc. 2017 Q1 - Results - Earnings Call Slides

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Diagnostic Testing Substances Manufacturers

Shares Out. (M)

14.16

Shares Float (M)

12.51

% Held by Insiders

11.70

% Held by Institutions

26.60

Shares Short (K)

66

Shares Short Prior Month (K)

73

Stock Financials

EPS

-0.440

EPS Est. Current Year

-0.520

EPS Est. Next Year

-0.200

EPS Est. Next Quarter

-0.090

Forward EPS

-0.070

Book Value (p.s.)

6.190

PEG Ratio

-1.72

Profit Margin

-21.29

Operating Margin

-21.58

Return on Assets (ttm)

-21.8

Return on Equity (ttm)

-26.3

Qtrly Rev. Growth

22.0

Gross Profit (p.s.)

0.384

Sales Per Share

EBITDA (p.s.)

-0.158

Qtrly Earnings Growth

Operating Cash Flow (M)

-3.48

Levered Free Cash Flow (M)

-2.07

atoplab.com

Valuation

P/E

-23.10

P/E Growth Ratio

-0.02

P/BV

1.64

P/S

70886496.00

P/CF

-41.36

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

2012-05-30

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.